NovoCure PE Ratio 2014-2023 | NVCR
Current and historical p/e ratio for NovoCure (NVCR) from 2014 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. NovoCure PE ratio as of April 22, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
NovoCure PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-04-22 | 11.83 | 0.00 | |
2023-12-31 | 14.93 | $-1.95 | 0.00 |
2023-09-30 | 16.15 | $-1.86 | 0.00 |
2023-06-30 | 41.50 | $-1.65 | 0.00 |
2023-03-31 | 60.14 | $-1.34 | 0.00 |
2022-12-31 | 73.35 | $-0.88 | 0.00 |
2022-09-30 | 75.98 | $-0.77 | 0.00 |
2022-06-30 | 69.50 | $-0.65 | 0.00 |
2022-03-31 | 82.85 | $-0.56 | 0.00 |
2021-12-31 | 75.08 | $-0.56 | 0.00 |
2021-09-30 | 116.17 | $-0.27 | 0.00 |
2021-06-30 | 221.82 | $-0.05 | 0.00 |
2021-03-31 | 132.18 | $0.11 | 1201.64 |
2020-12-31 | 173.04 | $0.19 | 910.74 |
2020-09-30 | 111.31 | $0.19 | 585.84 |
2020-06-30 | 59.30 | $0.12 | 494.17 |
2020-03-31 | 67.34 | $0.09 | 748.22 |
2019-12-31 | 84.27 | $-0.08 | 0.00 |
2019-09-30 | 74.78 | $-0.29 | 0.00 |
2019-06-30 | 63.23 | $-0.44 | 0.00 |
2019-03-31 | 48.17 | $-0.60 | 0.00 |
2018-12-31 | 33.48 | $-0.70 | 0.00 |
2018-09-30 | 52.40 | $-0.65 | 0.00 |
2018-06-30 | 31.30 | $-0.65 | 0.00 |
2018-03-31 | 21.80 | $-0.72 | 0.00 |
2017-12-31 | 20.20 | $-0.70 | 0.00 |
2017-09-30 | 19.85 | $-0.84 | 0.00 |
2017-06-30 | 17.30 | $-1.10 | 0.00 |
2017-03-31 | 8.10 | $1.68 | 4.82 |
2016-12-31 | 7.85 | $1.41 | 5.57 |
2016-09-30 | 8.54 | $1.25 | 6.83 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $1.273B | $0.509B |
NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $123.697B | 15.52 |
Cencora (COR) | United States | $47.247B | 18.86 |
ICON (ICLR) | Ireland | $24.578B | 24.24 |
DiDi Global (DIDIY) | China | $22.930B | 0.00 |
Avantor (AVTR) | United States | $16.557B | 22.81 |
CochLear (CHEOY) | $13.675B | 0.00 | |
Viatris (VTRS) | United States | $13.496B | 3.85 |
Revvity (RVTY) | United States | $12.448B | 21.67 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.029B | 0.00 |
Charles River Laboratories (CRL) | United States | $11.979B | 21.84 |
Medpace Holdings (MEDP) | United States | $11.658B | 38.35 |
Solventum (SOLV) | United States | $10.708B | 0.00 |
Natera (NTRA) | United States | $10.700B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.966B | 52.04 |
Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
Doximity (DOCS) | United States | $4.625B | 34.43 |
Organon (OGN) | United States | $4.601B | 4.46 |
PACS (PACS) | United States | $3.460B | 0.00 |
Progyny (PGNY) | United States | $3.177B | 53.32 |
Sotera Health (SHC) | United States | $3.139B | 15.40 |
Surgery Partners (SGRY) | United States | $3.044B | 28.28 |
Life Times (LTH) | United States | $2.774B | 30.65 |
GoodRx Holdings (GDRX) | United States | $2.631B | 133.20 |
Premier (PINC) | United States | $2.522B | 9.23 |
Teladoc Health (TDOC) | United States | $2.252B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.141B | 6.93 |
Agilon Health (AGL) | United States | $2.121B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.816B | 0.00 |
Agiliti (AGTI) | United States | $1.368B | 22.33 |
Establishment Labs Holdings (ESTA) | $1.325B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $0.947B | 0.00 |
Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
Embecta (EMBC) | United States | $0.617B | 4.08 |
InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.518B | 0.00 |
Enhabit (EHAB) | United States | $0.515B | 46.64 |
Auna S.A (AUNA) | Luxembourg | $0.466B | 0.00 |
CareDx (CDNA) | United States | $0.423B | 0.00 |
LifeMD (LFMD) | United States | $0.404B | 0.00 |
Beauty Health (SKIN) | United States | $0.404B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.395B | 0.00 |
DocGo (DCGO) | United States | $0.366B | 58.50 |
MultiPlan (MPLN) | United States | $0.356B | 0.00 |
Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
ModivCare (MODV) | United States | $0.312B | 4.14 |
GeneDx Holdings (WGS) | United States | $0.271B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
Sharecare (SHCR) | United States | $0.250B | 0.00 |
So-Young (SY) | China | $0.131B | 44.00 |
Biodesix (BDSX) | United States | $0.125B | 0.00 |
Oncology Institute (TOI) | United States | $0.084B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
NeueHealth (NEUE) | United States | $0.052B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.034B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
OpGen (OPGN) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |